Challener, C. A. (2019). Seeking Solutions for GMP Viral Vector Manufacturing: Innovation in manufacturing technologies must occur to ensure the availability of gene therapies and cell therapies. Pharmaceutical Technology Europe, 31(9), 16-19.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Challener, Cynthia A. "Seeking Solutions for GMP Viral Vector Manufacturing: Innovation in Manufacturing Technologies Must Occur to Ensure the Availability of Gene Therapies and Cell Therapies."
Pharmaceutical Technology Europe 31, no. 9 (2019): 16-19.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Challener, Cynthia A. "Seeking Solutions for GMP Viral Vector Manufacturing: Innovation in Manufacturing Technologies Must Occur to Ensure the Availability of Gene Therapies and Cell Therapies."
Pharmaceutical Technology Europe, vol. 31, no. 9, 2019, pp. 16-19.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.